Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Jeanne Drisko, MD, CNS, FACN
With
Cancer Treatment Research Foundation
University of Kansas Medical Center
The subjects are randomized to 2 study groups. Group 1 receives standard chemotherapy prescribed by the cancer doctor (carboplatin and paclitaxel)with a possible choice to extend chemotherapy for up to an additional 12 months.
Group 2 receives standard chemotherapy in the same manner as group 1. In addition, they receive 12 months of oral or IV nutritional supplements.
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
histologically confirmed carcinoma of the ovary stage III or IV
measurable or assessable disease
drug refractory ovarian cancer
must be 18 years of age or must have parental consent to enroll in the study
must be ambulatory
You may not be if
evidence of significant psychiatric disorder by history or exam
consumption of excess alcohol (more than 4 of any of the following per day: 30 ml distilled spirits, 340 ml beer, or 120 ml wine) or recreational drugs
tobacco use
prior treatment with an investigational drug, chemo, radiation therapy, or hormonal therapy within the preceeding month
